Related Experiment Video
Updated: Aug 28, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
[How is the management of diabetic hypertensive patients different?]
Anne Dufey Teso1, Faiza Lamine1,2,3, Anne Zanchi1,2
1Service de néphrologie et d'hypertension, Centre hospitalier universitaire vaudois, 1011 Lausanne.
Insights
High blood pressure is common in diabetes and increases risks. Treatment targets should be personalized, incorporating newer therapies that also reduce cardiovascular and kidney disease.
Area of Science:
- Cardiology
- Endocrinology
- Nephrology
Background:
- High blood pressure (HBP) is prevalent in diabetic patients, exacerbating diabetes complications and cardiovascular risk.
- Effective management of HBP is crucial for improving outcomes in this high-risk population.
Purpose of the Study:
- To highlight the importance of routine screening and tailored treatment of HBP in patients with diabetes.
- To discuss current and emerging therapeutic strategies for managing HBP in diabetic individuals.
Main Methods:
- Review of current clinical guidelines and recent pharmacological advancements for HBP management in diabetes.
- Analysis of treatment benefits beyond blood pressure reduction, focusing on cardiovascular and renal protection.
Main Results:
- Blood pressure targets (<130/80mmHg) require individualization based on patient age and comorbidities.
- Therapeutic options now extend beyond traditional renin-angiotensin-aldosterone system inhibitors.
- Emerging treatments like SGLT2 inhibitors, GLP-1 receptor agonists, and finerenone offer combined cardiovascular and renal risk reduction.
Conclusions:
- Aggressive and individualized management of HBP is essential in diabetic patients.
- Novel therapeutic agents provide significant benefits in reducing cardiovascular and renal complications in this population.
- The therapeutic landscape for HBP in diabetes is evolving, offering improved patient outcomes.
Abstract:
High blood pressure (HBP) is common in diabetic patients and significantly increases complications of diabetes and cardiovascular risk. It is therefore particularly important to routinely screen and treat HBP in these patients. Blood pressure targets in this population (<130/80mmHg) should be adapted to age and comorbidities. The therapeutic strategy has expanded beyond renin-angiotensin-aldosterone system inhibitors in the diabetic population, with treatments which decrease cardiovascular and renal risk, such as SGLT2 inhibitors, GLP-1 receptor agonists, and soon finerenone.
Related Concept Videos
Hypertension V: Nursing Management
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypertension IV: Drug Therapy and Lifestyle Modifications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Hypertension and Regulation of Blood Pressure

